Belite Bio, Inc (BLTE)

Belite Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	352.93	31.68	88.16	42.09	17.34
Short-Term Investments	-	139.49	113.47	-	-	-
Cash & Short-Term Investments	-	492.42	145.15	88.16	42.09	17.34
Cash Growth	-	239.25%	64.65%	109.45%	142.67%	-32.30%
Other Receivables	-	0.7	0.58	0.84	0	-
Receivables	-	0.7	0.58	0.84	0	-
Prepaid Expenses	-	1.13	1.33	0.92	0.7	0.06
Other Current Assets	501.6	0.02	0.02	0.03	0.02	0.02
Total Current Assets	501.6	494.27	147.07	89.94	42.81	17.43
Property, Plant & Equipment	-	0.78	0.97	1.3	1.35	0.09
Long-Term Investments	-	280.17	-	-	-	-
Other Intangible Assets	-	0.02	0.03	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.82
Other Long-Term Assets	289.98	5.32	4.06	3.4	0.12	0.01
Total Assets	791.58	780.56	152.13	94.64	44.27	18.35

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	-	7.31	4.86	3.18	1.83	1.54
Current Portion of Leases	-	0.24	0.28	0.31	0.2	-
Other Current Liabilities	14.95	2.33	0.92	0.15	0.07	0.1
Total Current Liabilities	14.95	9.88	6.05	3.63	2.1	1.64
Long-Term Leases	-	0.19	0.26	0.58	0.67	-
Total Liabilities	14.95	10.07	6.31	4.21	2.77	1.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	776.64	0	0	0	0	0
Additional Paid-In Capital	-	956.28	254.13	162.31	81.76	12.33
Retained Earnings	-	-185.26	-107.65	-71.5	-39.87	-27.22
Comprehensive Income & Other	-	-0.54	-0.66	-0.37	-0.39	-0.2
Total Common Equity	776.64	770.49	145.82	90.43	41.5	-15.09
Shareholders' Equity	776.64	770.49	145.82	90.43	41.5	16.71
Total Liabilities & Equity	791.58	780.56	152.13	94.64	44.27	18.35

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	0.43	0.54	0.89	0.87	-
Net Cash (Debt)	-	491.99	144.61	87.27	41.22	17.34
Net Cash Growth	-	240.22%	65.70%	111.71%	137.68%	-32.30%
Net Cash Per Share	-	14.67	4.74	3.28	2.06	1.81
Filing Date Shares Outstanding	40.27	39.34	31.83	29.15	24.9	10.27
Total Common Shares Outstanding	40.27	39.34	31.83	29.15	24.9	10.27
Working Capital	486.65	484.39	141.02	86.31	40.7	15.8
Book Value Per Share	19.28	19.59	4.58	3.10	1.67	-1.47
Tangible Book Value	776.64	770.47	145.79	90.43	41.5	-15.09
Tangible Book Value Per Share	19.28	19.58	4.58	3.10	1.67	-1.47
Machinery	-	0.66	0.6	0.49	0.45	0.14
Leasehold Improvements	-	0.19	0.19	0.19	0.19	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error